Soleno Therapeutics (SLNO) Beats Q4 Earnings Estimates by $0.12
Soleno Therapeutics (NASDAQ:SLNO) reported quarterly earnings results on February 25, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share…
Read more
